Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ENOV · against 1,372 other Healthcare companies
Ranked #1,157 of 1,373 · scores higher than 16% of peers · safety percentile 16
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)137 peers with a safety percentile of 10–19, including ENOV · Click a bar to see the companies
Mainly because of its beta and debt / equity, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | ENOV | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 1,280 reported | 0.93× | 0.24× | 17% | 33% | |
| BetaLower is better · 1,320 reported | 1.42 | 0.53 | 12% | 33% | |
| Current ratioHigher is better · 1,338 reported | 1.99× | 2.62× | 40% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 1,153 | 21.3B KRW (≈$15M) | 16 | 28 | |
| 1,154 | 7.1B CNY (≈$988M) | 16 | 46 | |
| 1,155 | 8.7B USD | 16 | 26 | |
| 1,156 | 519M USD | 16 | 22 | |
| 1,157 | 1.2B USD | 16 | 46 | |
| 1,158 | 11.1B BRL (≈$2.0B) | 16 | 60 | |
| 1,159 | 1.5B USD | 16 | 65 | |
| 1,160 | 5.8B USD | 16 | 64 | |
| 1,161 | 885M USD | 15 | 33 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score